Plaque Brachytherapy for Uveal Melanoma: A Vision Prognostication Model
- 1 November 2012
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 84 (3), e285-e290
- https://doi.org/10.1016/j.ijrobp.2012.04.005
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Ocular complications following I-125 brachytherapy for choroidal melanomaEye, 2009
- Proton Beam Irradiation of Uveal Melanomas: The First 30 Years The Weisenfeld LecturePublished by Association for Research in Vision and Ophthalmology (ARVO) ,2006
- Visual acuity after Ruthenium106 brachytherapy of choroidal melanomasInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years’ experience with beta-rays)American Journal of Ophthalmology, 2004
- A reanalysis of the Collaborative Ocular Melanoma Study Medium Tumor Trial eye plaque dosimetryInternational Journal of Radiation Oncology*Biology*Physics, 2003
- The COMS randomized trial of iodine 125 brachytherapy for choroidal melanomaOphthalmology, 2002
- Posttreatment visual acuity in patients treated with episcleral plaque therapy for choroidal melanomas: dose and dose rate effectsInternational Journal of Radiation Oncology*Biology*Physics, 2002
- The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma, III: Initial Mortality FindingsAmerican Journal of Ophthalmology, 2001
- Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma I. visual acuity after 3 years COMS report no. 16Ophthalmology, 2001
- Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma.British Journal of Ophthalmology, 1996